Toll Free: 1-888-928-9744
Published: Mar, 2015 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Advenchen Laboratories, LLC - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Advenchen Laboratories, LLC - Product Pipeline Review - 2015', provides an overview of the Advenchen Laboratories, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advenchen Laboratories, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Advenchen Laboratories, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Advenchen Laboratories, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Advenchen Laboratories, LLC's pipeline products Reasons To Buy - Evaluate Advenchen Laboratories, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Advenchen Laboratories, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Advenchen Laboratories, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Advenchen Laboratories, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advenchen Laboratories, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Advenchen Laboratories, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Advenchen Laboratories, LLC Snapshot 5 Advenchen Laboratories, LLC Overview 5 Key Information 5 Key Facts 5 Advenchen Laboratories, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 Advenchen Laboratories, LLC - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Advenchen Laboratories, LLC - Pipeline Products Glance 11 Advenchen Laboratories, LLC - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Advenchen Laboratories, LLC - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Advenchen Laboratories, LLC - Early Stage Pipeline Products 14 IND/CTA Filed Products/Combination Treatment Modalities 14 Preclinical Products/Combination Treatment Modalities 15 Advenchen Laboratories, LLC - Drug Profiles 16 apatinib 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 AL-3818 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 lucitanib 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 AL-6802 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 AL-2846 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 AL-8326 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 AL-58203 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 AL-58805 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Advenchen Laboratories, LLC - Pipeline Analysis 28 Advenchen Laboratories, LLC - Pipeline Products by Target 28 Advenchen Laboratories, LLC - Pipeline Products by Route of Administration 30 Advenchen Laboratories, LLC - Pipeline Products by Molecule Type 31 Advenchen Laboratories, LLC - Pipeline Products by Mechanism of Action 32 Advenchen Laboratories, LLC - Recent Pipeline Updates 34 Advenchen Laboratories, LLC - Dormant Projects 36 Advenchen Laboratories, LLC - Locations And Subsidiaries 37 Head Office 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 38 Disclaimer 39
List of Tables Advenchen Laboratories, LLC, Key Information 5 Advenchen Laboratories, LLC, Key Facts 5 Advenchen Laboratories, LLC - Pipeline by Indication, 2015 7 Advenchen Laboratories, LLC - Pipeline by Stage of Development, 2015 9 Advenchen Laboratories, LLC - Monotherapy Products in Pipeline, 2015 10 Advenchen Laboratories, LLC - Phase III, 2015 11 Advenchen Laboratories, LLC - Phase II, 2015 12 Advenchen Laboratories, LLC - Phase I, 2015 13 Advenchen Laboratories, LLC - IND/CTA Filed, 2015 14 Advenchen Laboratories, LLC - Preclinical, 2015 15 Advenchen Laboratories, LLC - Pipeline by Target, 2015 28 Advenchen Laboratories, LLC - Pipeline by Route of Administration, 2015 30 Advenchen Laboratories, LLC - Pipeline by Molecule Type, 2015 31 Advenchen Laboratories, LLC - Pipeline Products by Mechanism of Action, 2015 33 Advenchen Laboratories, LLC - Recent Pipeline Updates, 2015 34 Advenchen Laboratories, LLC - Dormant Developmental Projects,2015 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.